Cabenuva (cabotegravir long acting/rilpivirine long acting) - J&J, GSK, ViiV Healthcare, Pfizer, Shionogi
https://idweek2026.eventscribe.net/fsPopup.asp?PosterID=838902&mode=posterInfo
 
Luis Buzón-Martín, MD (he/him/his); Noemí Cabello, MD/PhD; Jose I Bernardino, MD; María José Galindo, MD, PhD; Rosa María Martínez, MD; Mireia Santacreu, n/a; Lucía Romero, MD; Miguel Torralba, MD/PHD; Francisco Fanjul, n/a; Roberto Pedrero Tomé, PhD Student (he/him/his); Paula Runza, MD; Adrian Rodriguez, PhD; María José Crusells, MD; María del Carmen Navarro, MD; Javier Pérez, MD; Carmen Hidalgo, n/a; Luis Morano, MD; David Vinuesa, MD; Enrique Bernal, MD, PhD; Carlos de Andrés, MD; Hadrián Pernas, MD; Juan Manuel Tiraboschi, PhD; María del Carmen Montero, MD; María Jesús Vivancos, MD; Cristina Díez, MD; Guillermo Soria, MD; Desiré Pérez, MD; Laura Gisbert, n/a; Alberto Romero, MD; Rebeca Cabo, MD; Josefa Francisca Soler, MD; María Antonia Sepúlveda, MD; Cristina Escrich, MD; Joaquin Bravo, MD; Eva Ferreira, MD; Jessica Abadía, MD; Ana Lérida, MD; Ana Lucas, MD; Sara García, MD; Juan Emilio Losa, MD; Ana Cerezales, MD; D Jose Sanz-Moreno, MD; Mar Masiá, MD, PhD; Juan José Corte, PharmD; Marta Millán, MD; Mikel del Álamo, MD; Miguel V. Egido Murciano, MD; Oscar Luis Ferrero, MD; Patricia Barragan, MD; Jesús Troya, MD PhD (he/him/his)
 
Sep 6, 2026
 
Prev Next